Publication | Closed Access

Targeting self-enhanced ROS-responsive artesunatum prodrug nanoassembly potentiates gemcitabine activity by down-regulating CDA expression in cervical cancer

NanomedicineDrug TargetingEngineeringCervical CancerPolymer-drug ConjugateMedicineDown-regulating Cda ExpressionTumor TargetingNano-drug DeliveryPharmacologyRadiation OncologyTumor MicroenvironmentGemcitabine ActivityBiomolecular Engineering